Clinical Evaluation of the QuantiFERON CMV Assay



Status:Recruiting
Healthy:No
Age Range:18 - Any
Updated:2/9/2019
Start Date:November 15, 2018
End Date:June 30, 2019
Contact:Andrew E Schumacher, BS
Email:andrew.schumacher@qiagen.com
Phone:301-944-7094

Use our guide to learn which trials are right for you!

Validate the use of the device in the clinical setting for assessing the risk of CMV
Infection in SOT recipients after the completion of antiviral prophylaxis.


Inclusion Criteria:

- Adult CMV D+/R- liver, kidney, heart, pancreas, lung, intestinal, or combined
transplant recipients that are 18 years of age or older.

- Scheduled to receive between 3 to 6 months of antiviral prophylaxis

- Provide Informed Consent

Exclusion Criteria:

- Subjects less than 18 years old

- Scheduled to receive longer than 6 months or shorter than 3 months of prophylaxis

- Unable to provide Informed Consent
We found this trial at
1
site
200 Lothrop St
Pittsburgh, Pennsylvania 15213
Principal Investigator: Fernanda Silveira, MD
Phone: 412-648-6553
University of Pittsburgh Medical Center UPMC is one of the leading nonprofit health systems in...
?
mi
from
Pittsburgh, PA
Click here to add this to my saved trials